NIH's Role In Sustaining the U.S. Economy 2021 Update Now Available here
UMR Urges House and Senate Leaders to Include NIH Funding in COVID Relief Package read here
UMR releases new fact sheets on COVID-19 and biomedical research. Read here
See how UMR members are aiding in the fight against the coronavirus here
A new episode of the Amazing Things Podcast is now available! Check it out here.

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

Public health researchers call for new measures to protect pharmaceutical supply chain

Shortages of many essential drugs amid the COVID-19 crisis reveal serious vulnerabilities in the systems for supplying and distributing pharmaceuticals in the United States, according to a new report led by researchers at the Johns Hopkins Bloomberg School of Public Health.

In the report‚ “The Pandemic and the Supply Chain‚” the researchers identify multiple problems in the drug supply chain, and then recommend specific policy actions that the Food and Drug Administration and Congress could take to reduce current drug shortages and prevent future shortages—creating incentives for more U.S.-based production of essential pharmaceuticals, for example.